Brief: United Laboratories International Flaunts U.S. FDA Approval Of IND For UBT37034 Injection
10/07/2025 09:15
July 10 (Reuters) - United Laboratories International Holdings Ltd 3933.HK: U.S. FDA APPROVAL OF IND FOR UBT37034 INJECTION Further company coverage: 3933.HK ((Reuters.Briefs@thomsonreuters.com))
Recent news on United Laboratories International Holdings
See all newsBrief: United Laboratories International Receives Milestone Payment From Novo
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million